You just read:

Completion of Phase I Clinical Trial of Novel Syk Inhibitor HMPL-523 for Autoimmune Diseases in Healthy Volunteers

News provided by

Hutchison China MediTech Limited

30 Oct, 2015, 07:57 GMT